The effects of antioxidant nanomaterials on organ ischemia with inadequate oxygen supply followed by reperfusion occured in different clinical conditions and surgical procedures including stroke, myocardial infarction, limb ischemia, renal failure, organ transplantation, free-tissue-transfer, cardiopulmonary bypass, and vascular surgery.